These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25439675)

  • 21. Percutaneous tumor ablation: reduced tumor growth with combined radio-frequency ablation and liposomal doxorubicin in a rat breast tumor model.
    D'Ippolito G; Ahmed M; Girnun GD; Stuart KE; Kruskal JB; Halpern EF; Goldberg SN
    Radiology; 2003 Jul; 228(1):112-8. PubMed ID: 12808127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoxia-inducible transcription factor-1 alpha determines sensitivity of endothelial cells to the proteosome inhibitor bortezomib.
    Veschini L; Belloni D; Foglieni C; Cangi MG; Ferrarini M; Caligaris-Cappio F; Ferrero E
    Blood; 2007 Mar; 109(6):2565-70. PubMed ID: 17110461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic siRNA Nanoparticle-Based Drugs Combined with Radiofrequency Ablation for Cancer Therapy.
    Ahmed M; Kumar G; Navarro G; Wang Y; Gourevitch S; Moussa MH; Rozenblum N; Levchenko T; Galun E; Torchilin VP; Goldberg SN
    PLoS One; 2015; 10(7):e0128910. PubMed ID: 26154425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemoradionuclide therapy with 186Re-labeled liposomal doxorubicin in combination with radiofrequency ablation for effective treatment of head and neck cancer in a nude rat tumor xenograft model.
    Soundararajan A; Dodd GD; Bao A; Phillips WT; McManus LM; Prihoda TJ; Goins BA
    Radiology; 2011 Dec; 261(3):813-23. PubMed ID: 22025735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bortezomib inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated repression of hypoxia-inducible factor-1.
    Shin DH; Chun YS; Lee DS; Huang LE; Park JW
    Blood; 2008 Mar; 111(6):3131-6. PubMed ID: 18174379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic Thermal Ablation: Effect of Device and Heating Parameters on Local Tissue Reactions and Distant Tumor Growth.
    Velez E; Goldberg SN; Kumar G; Wang Y; Gourevitch S; Sosna J; Moon T; Brace CL; Ahmed M
    Radiology; 2016 Dec; 281(3):782-792. PubMed ID: 27409564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting hypoxia-inducible factor-1α (HIF-1α) in combination with antiangiogenic therapy: a phase I trial of bortezomib plus bevacizumab.
    Falchook GS; Wheler JJ; Naing A; Jackson EF; Janku F; Hong D; Ng CS; Tannir NM; Lawhorn KN; Huang M; Angelo LS; Vishwamitra D; Hess K; Howard AN; Parkhurst KL; Amin HM; Kurzrock R
    Oncotarget; 2014 Nov; 5(21):10280-92. PubMed ID: 25373733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIF-1α of bone marrow endothelial cells implies relapse and drug resistance in patients with multiple myeloma and may act as a therapeutic target.
    Ria R; Catacchio I; Berardi S; De Luisi A; Caivano A; Piccoli C; Ruggieri V; Frassanito MA; Ribatti D; Nico B; Annese T; Ruggieri S; Guarini A; Minoia C; Ditonno P; Angelucci E; Derudas D; Moschetta M; Dammacco F; Vacca A
    Clin Cancer Res; 2014 Feb; 20(4):847-58. PubMed ID: 24297864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phase II trial with pharmacodynamic endpoints of the proteasome inhibitor bortezomib in patients with metastatic colorectal cancer.
    Mackay H; Hedley D; Major P; Townsley C; Mackenzie M; Vincent M; Degendorfer P; Tsao MS; Nicklee T; Birle D; Wright J; Siu L; Moore M; Oza A
    Clin Cancer Res; 2005 Aug; 11(15):5526-33. PubMed ID: 16061869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Percutaneous tumor ablation: increased necrosis with combined radio-frequency ablation and intratumoral doxorubicin injection in a rat breast tumor model.
    Goldberg SN; Saldinger PF; Gazelle GS; Huertas JC; Stuart KE; Jacobs T; Kruskal JB
    Radiology; 2001 Aug; 220(2):420-7. PubMed ID: 11477246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteasome inhibition with bortezomib induces cell death in GBM stem-like cells and temozolomide-resistant glioma cell lines, but stimulates GBM stem-like cells' VEGF production and angiogenesis.
    Bota DA; Alexandru D; Keir ST; Bigner D; Vredenburgh J; Friedman HS
    J Neurosurg; 2013 Dec; 119(6):1415-23. PubMed ID: 24093630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of bortezomib on VEGF gene expression of endothelial cell line HMEC-1 and its possible mechanisms].
    Xue LX; Jiang M; Xie LQ; Ruan CG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):744-8. PubMed ID: 20561442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved tumor destruction with arsenic trioxide and radiofrequency ablation in three animal models.
    Hines-Peralta A; Sukhatme V; Regan M; Signoretti S; Liu ZJ; Goldberg SN
    Radiology; 2006 Jul; 240(1):82-9. PubMed ID: 16720872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination radiofrequency ablation and intravenous radiolabeled liposomal Doxorubicin: imaging and quantification of increased drug delivery to tumors.
    Head HW; Dodd GD; Bao A; Soundararajan A; Garcia-Rojas X; Prihoda TJ; McManus LM; Goins BA; Santoyo CA; Phillips WT
    Radiology; 2010 May; 255(2):405-14. PubMed ID: 20413753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incomplete radiofrequency ablation accelerates proliferation and angiogenesis of residual lung carcinomas via HSP70/HIF-1α.
    Wan J; Wu W; Huang Y; Ge W; Liu S
    Oncol Rep; 2016 Aug; 36(2):659-68. PubMed ID: 27278081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Irreversible Electroporation versus Radiofrequency Ablation: A Comparison of Local and Systemic Effects in a Small-Animal Model.
    Bulvik BE; Rozenblum N; Gourevich S; Ahmed M; Andriyanov AV; Galun E; Goldberg SN
    Radiology; 2016 Aug; 280(2):413-24. PubMed ID: 27429143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does Thermosensitive Liposomal Vinorelbine Improve End-Point Survival after Percutaneous Radiofrequency Ablation of Liver Tumors in a Mouse Model?
    Wang S; Mei XG; Goldberg SN; Ahmed M; Lee JC; Gong W; Han HB; Yan K; Yang W
    Radiology; 2016 Jun; 279(3):762-72. PubMed ID: 26785043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bortezomib is ineffective in an orthotopic mouse model of pancreatic adenocarcinoma.
    Märten A; Zeiss N; Serba S; Mehrle S; von Lilienfeld-Toal M; Schmidt J
    Mol Cancer Ther; 2008 Nov; 7(11):3624-31. PubMed ID: 19001444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The potential role of hypoxia inducible factor 1alpha in tumor progression after hypoxia and chemotherapy in hepatocellular carcinoma.
    Yang ZF; Poon RT; To J; Ho DW; Fan ST
    Cancer Res; 2004 Aug; 64(15):5496-503. PubMed ID: 15289360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Control of HIF-1alpha expression by eIF2 alpha phosphorylation-mediated translational repression.
    Zhu K; Chan W; Heymach J; Wilkinson M; McConkey DJ
    Cancer Res; 2009 Mar; 69(5):1836-43. PubMed ID: 19244104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.